AWM
BSX icon

AE Wealth Management’s Boston Scientific BSX Stock Holding History

AE Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Sell
56,355
-150,248
-73% -$8.16M 0.01% 602
2026
Q1 		$13M Buy
206,603
+28,720
+16% +$2.3M 0.07% 263
2025
Q4 		$17M Buy
177,883
+163,615
+1,147% +$16M 0.1% 214
2025
Q3 		$1.39M Sell
14,268
-5,598
-28% -$580K 0.01% 669
2025
Q2 		$2.13M Buy
19,866
+1,280
+7% +$130K 0.02% 522
2025
Q1 		$1.87M Sell
18,586
-47,676
-72% -$4.8M 0.02% 544
2024
Q4 		$5.92M Buy
66,262
+3,607
+6% +$318K 0.05% 314
2024
Q3 		$5.25M Buy
62,655
+46,394
+285% +$3.66M 0.05% 322
2024
Q2 		$1.25M Buy
16,261
+2,582
+19% +$189K 0.01% 650
2024
Q1 		$937K Sell
13,679
-20,981
-61% -$1.35M 0.01% 662
2023
Q4 		$2.12M Buy
34,660
+286
+0.8% +$15.3K 0.01% 884
2023
Q3 		$1.81M Buy
34,374
+3,091
+10% +$162K 0.01% 881
2023
Q2 		$1.69M Buy
31,283
+4,887
+19% +$255K 0.01% 891
2023
Q1 		$1.32M Buy
26,396
+20,033
+315% +$944K 0.01% 940
2022
Q4 		$294K Sell
6,363
-1,291
-17% -$55.9K ﹤0.01% 1507
2022
Q3 		$296K Buy
7,654
+1,841
+32% +$73.9K ﹤0.01% 1479
2022
Q2 		$217K Sell
5,813
-1,220
-17% -$49.7K ﹤0.01% 1569
2022
Q1 		$311K Buy
7,033
+620
+10% +$26.9K ﹤0.01% 1402
2021
Q4 		$272K Sell
6,413
-444
-6% -$18.7K ﹤0.01% 1482
2021
Q3 		$298K Sell
6,857
-31,318
-82% -$1.39M ﹤0.01% 1363
2021
Q2 		$1.63M Sell
38,175
-33,156
-46% -$1.39M 0.01% 690
2021
Q1 		$2.76M Sell
71,331
-107
-0.1% -$4.05K 0.03% 481
2020
Q4 		$2.57M Buy
71,438
+24,259
+51% +$874K 0.03% 429
2020
Q3 		$1.8M Buy
47,179
+43
+0.1% +$1.66K 0.03% 459
2020
Q2 		$1.66M Buy
47,136
+5,292
+13% +$191K 0.03% 466
2020
Q1 		$1.36M Buy
41,844
+35,732
+585% +$1.4M 0.03% 410
2019
Q4 		$276K Sell
6,112
-72
-1% -$3.01K 0.01% 933
2019
Q3 		$252K Sell
6,184
-2,398
-28% -$102K 0.01% 844
2019
Q2 		$369K Buy
+8,582
New +$330K 0.01% 677

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AE Wealth Management's BSX Position: Q2 2026 in Review

AE Wealth Management reduced its Boston Scientific (BSX) stake by 73% in Q2 2026, selling an estimated $8.16M and leaving 56,355 shares worth $2.41M. The position accounts for 0.01% of the portfolio, ranked #602.

AE Wealth Management first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $17M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AE Wealth Management held 56,355 shares of Boston Scientific worth $2.41M as of Q2 2026.
  • AE Wealth Management sold 150,248 Boston Scientific shares in Q2 2026, an estimated $8.16M.
  • Boston Scientific made up 0.01% of AE Wealth Management's portfolio in Q2 2026, its #602 holding.
  • AE Wealth Management first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
  • AE Wealth Management's Boston Scientific position peaked at $17M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.